Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation

There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosas, Melissa M, Sobieszczyk, Michal J, Warren, Whittney, Mason, Phillip, Walter, Robert J, Marcus, Joseph E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356672/
https://www.ncbi.nlm.nih.gov/pubmed/35949400
http://dx.doi.org/10.1093/ofid/ofac374
_version_ 1784763570793218048
author Rosas, Melissa M
Sobieszczyk, Michal J
Warren, Whittney
Mason, Phillip
Walter, Robert J
Marcus, Joseph E
author_facet Rosas, Melissa M
Sobieszczyk, Michal J
Warren, Whittney
Mason, Phillip
Walter, Robert J
Marcus, Joseph E
author_sort Rosas, Melissa M
collection PubMed
description There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.
format Online
Article
Text
id pubmed-9356672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93566722022-08-09 Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation Rosas, Melissa M Sobieszczyk, Michal J Warren, Whittney Mason, Phillip Walter, Robert J Marcus, Joseph E Open Forum Infect Dis Brief Report There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections. Oxford University Press 2022-07-25 /pmc/articles/PMC9356672/ /pubmed/35949400 http://dx.doi.org/10.1093/ofid/ofac374 Text en Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Brief Report
Rosas, Melissa M
Sobieszczyk, Michal J
Warren, Whittney
Mason, Phillip
Walter, Robert J
Marcus, Joseph E
Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title_full Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title_fullStr Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title_full_unstemmed Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title_short Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation
title_sort outcomes of fungemia in patients receiving extracorporeal membrane oxygenation
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356672/
https://www.ncbi.nlm.nih.gov/pubmed/35949400
http://dx.doi.org/10.1093/ofid/ofac374
work_keys_str_mv AT rosasmelissam outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation
AT sobieszczykmichalj outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation
AT warrenwhittney outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation
AT masonphillip outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation
AT walterrobertj outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation
AT marcusjosephe outcomesoffungemiainpatientsreceivingextracorporealmembraneoxygenation

Ejemplares similares